Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1960 1
1961 2
1962 3
1964 1
1965 1
1966 1
1967 2
1968 5
1969 5
1970 5
1971 4
1972 9
1973 4
1974 11
1975 5
1976 9
1977 6
1978 8
1979 11
1980 13
1981 11
1982 8
1983 10
1984 11
1985 15
1986 13
1987 16
1988 15
1989 15
1990 9
1991 11
1992 18
1993 13
1994 12
1995 6
1996 5
1997 2
1998 1
1999 5
2000 2
2001 4
2002 2
2003 5
2004 5
2005 3
2006 9
2007 11
2008 12
2009 20
2010 5
2011 12
2012 13
2013 11
2014 22
2015 12
2016 19
2017 19
2018 25
2019 15
2020 20
2021 17
2022 18
Text availability
Article attribute
Article type
Publication date

Search Results

542 results
Results by year
Filters applied: . Clear all
Page 1
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).
Yamamoto Y, Iwata H, Taira N, Masuda N, Takahashi M, Yoshinami T, Ueno T, Toyama T, Yamanaka T, Takano T, Kashiwaba M, Tsugawa K, Hasegawa Y, Tamura K, Tada H, Hara F, Fujisawa T, Niikura N, Saji S, Morita S, Toi M, Ohno S. Yamamoto Y, et al. Among authors: taira n. Cancer Sci. 2022 Sep;113(9):3169-3179. doi: 10.1111/cas.15474. Epub 2022 Jul 23. Cancer Sci. 2022. PMID: 35754298 Free PMC article. Clinical Trial.
Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
Hagiwara Y, Shiroiwa T, Taira N, Kawahara T, Konomura K, Noto S, Fukuda T, Shimozuma K. Hagiwara Y, et al. Among authors: taira n. Health Qual Life Outcomes. 2020 Nov 3;18(1):354. doi: 10.1186/s12955-020-01611-w. Health Qual Life Outcomes. 2020. PMID: 33143687 Free PMC article.
Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.
Saji S, Taira N, Kitada M, Takano T, Takada M, Ohtake T, Toyama T, Kikawa Y, Hasegawa Y, Fujisawa T, Kashiwaba M, Ishida T, Nakamura R, Yamamoto Y, Toh U, Iwata H, Masuda N, Morita S, Ohno S, Toi M. Saji S, et al. Among authors: taira n. Lancet Oncol. 2022 May;23(5):636-649. doi: 10.1016/S1470-2045(22)00196-6. Epub 2022 Apr 8. Lancet Oncol. 2022. PMID: 35405087 Clinical Trial.
Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients.
Sawaki M, Taira N, Uemura Y, Saito T, Baba S, Kobayashi K, Kawashima H, Tsuneizumi M, Sagawa N, Bando H, Takahashi M, Yamaguchi M, Takashima T, Nakayama T, Kashiwaba M, Mizuno T, Yamamoto Y, Iwata H, Kawahara T, Ohashi Y, Mukai H; RESPECT study group. Sawaki M, et al. Among authors: taira n. J Clin Oncol. 2020 Nov 10;38(32):3743-3752. doi: 10.1200/JCO.20.00184. Epub 2020 Sep 16. J Clin Oncol. 2020. PMID: 32936713 Clinical Trial.
[Nifedipine: a novel vasodilator].
Taira N. Taira N. Drugs. 2006;66 Spec No 1:1-3. doi: 10.2165/00003495-200666991-00002. Drugs. 2006. PMID: 18203343 Review. Japanese.
Desmoid-type fibromatosis of the breast mimicking cancer.
Otani Y, Taira N, Doihara H. Otani Y, et al. Among authors: taira n. Jpn J Clin Oncol. 2020 Sep 5;50(9):1084-1085. doi: 10.1093/jjco/hyz209. Jpn J Clin Oncol. 2020. PMID: 32083288 No abstract available.
Signet-ring cell lymphoma.
Nagasaki A, Oshiro A, Miyagi T, Sakihara M, Oshima K, Kikuchi M, Okudaira T, Nakazato T, Shinjo T, Taira N, Takasu N, Masuda M. Nagasaki A, et al. Among authors: taira n. Intern Med. 2003 Oct;42(10):1055-6. doi: 10.2169/internalmedicine.42.1055. Intern Med. 2003. PMID: 14606729 Free article. No abstract available.
Evaluation of Prognosis of Juvenile Differentiated Thyroid Carcinoma.
Tsukioki T, Shien T, Ohtani Y, Fujihara M, Suzuki Y, Kajihara Y, Hatono M, Kawada K, Kochi M, Iwamoto T, Ikeda H, Taira N, Doihara H. Tsukioki T, et al. Among authors: taira n. Acta Med Okayama. 2020 Oct;74(5):401-406. doi: 10.18926/AMO/60799. Acta Med Okayama. 2020. PMID: 33106695 Free article.
542 results